Avemar was presented at Taiwan Joint Cancer Conference which is the largest Cancer Conference in Taiwan. It is composed by 8 medical societies, which are The Taiwan Genomics and Genetics Society, The Chinese Oncology Society, Taiwan Clinical Oncology Society, Taiwan Lung Cancer Society, The Breast Cancer Society of Taiwan, Society of Gynecologic Oncology (R.O.C), Taiwan Association of Gynecologic Oncologists and Taiwan Society for Therapeutic Radiology and Oncology.
The Taiwan Joint Cancer Conference is annually held in Taiwan and every year, numerous native and foreign experts, scholars, and cancer specialists participate in this grand occasion to exchange frontier cancer news and research outcomes in an interdisciplinary approach.
The 18th Annual Taiwan Joint Cancer Conference was held on July 13th and 14th, 2013 at National Taiwan University International Convention Center, Taipei, and hosted by Taiwan Genomics and Genetics Society. This year conference's theme was: New Frontiers for Cancer Therapy. Avemar, which has been studied by local researchers and physicians, has yielded excellent results against both liver and ovarian cancer cell lines. The studies were presented to the medical professionals participating in this event.
Below is the full text of the article in original Chinese language: